Veterinary World

     Open access and peer reviewed journal  

ISSN (Online): 2231-0916

ISSN (Print): 0972-8988


Home l Editorial board l Instructions for authors l Reviewer guideline l Open access policy l Archives l FAQ

Open Access

Copyright: The authors. This article is an open access article licensed under the terms of the Creative Commons Attribution License ( which permits unrestricted use, distribution and reproduction in any medium, provided the work is properly cited.

Review (Published online: 08-05-2014)

6. Adverse drug reaction and toxicity caused by commonly used antimicrobials in canine practice - K. Arunvikram, Ipsita Mohanty, K. K. Sardar, S. Palai, G. Sahoo and R. C. Patra
Veterinary World, 7(5): 299-305



   doi: 10.14202/vetworld.2014.299-305



K. Arunvikram: Division of Pharmacology and Toxicology, Indian Veterinary Research Institute, Izatnagar -243122, Uttar Pradesh, India

Ipsita Mohanty: Department of Pharmacology and Toxicology, Veterinary College, Orissa University of Agricultural and Technology, Bhubaneswar - 751 003, Odisha, India

K. K. Sardar: Department of Pharmacology and Toxicology, Veterinary College, Orissa University of Agricultural and Technology, Bhubaneswar - 751 003, Odisha, India

S. Palai: Department of Pharmacology and Toxicology, Veterinary College, Orissa University of Agricultural and Technology, Bhubaneswar - 751 003, Odisha, India

G. Sahoo: Department of Biochemistry, Veterinary College, Orissa University of Agricultural and Technology, Bhubaneswar - 751 003, Odisha, India

R. C. Patra: Department of Clinical Medicine, Veterinary College, Orissa University of Agricultural and Technology, Bhubaneswar - 751 003, Odisha, India

Received: 20-03-2014, Revised: 05-04-2014, Accepted: 08-04-2014, Published online: 08-05-2014

Corresponding author:
Ipsita Mohanty, email:


1. Carleton B., Poole R., Smith M., Leeder J., Ghannadan R., Ross C., Phillips M. and Hayden, M. (2009) Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals, Pharmacoepidem. Drug Saf., 18: 713–721.
2. Singh A. and Bhatt P. (2012) Comparative evaluation of adverse drug reaction reporting forms for introduction of a spontaneous generic ADR form, J. Pharmacol. Pharmacother., 3(3): 228–232.
PMid:23129957 PMCid:PMC3487270
3. Dogan F. (2011) Pharmacovigilance in veterinary profession, Euras. J. Vet. Sci., 27(1): 19-25.
4. Mealey K.L. (2004) Clinically significant drug interactions. 19th Proceedings of AAVD & ACVD annual meeting (North American Dermatology Forum). p45-49.
5. Lopez-Gonzalez E., Herdeiro M.T. and Figueiras, A. (2009) Determinants of Under-Reporting of Adverse Drug Reactions, Drug Saf., 32(1): 19-31.
6. Ramya B., Anjaneyulu Y., Gopala Reddy A., Madhuri D., Lakshman M. and Shivakumar, P. (2013) Protective role of turmeric on histological, ultrastructural and serobiochemical changes in cisplatin-induced nephrotoxicity in female rats, Vet. World, 6: 865- 869.
7. Naisbitt D.J., Gordon S.F., Pirmohamed M. and Park, B.K. (2000) Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment, Drug Saf., 23: 483–507.
8. DeShazo R.D. and Kemp S.F. (1997) Allergic reactions to drugs and biologic agents, J. Am. Med. Assoc., 278: 1895– 1906.
9. Roychowdhury S. and Svensson C.K. (2005) Mechanisms of Drug-induced Delayed-type Hypersensitivity Reactions in the Skin, Am. Assoc. Pharmac. Sci. J., 7(4): E834-E846.
10. Barranco P. and Lopez-Serrano M.C. (1998) General and epidemiological aspects of allergic drug reactions, Clin. Exp. Allergy, 28(4): 61–2.
11. Adkinson N.F. (1984) Jr. Risk factors for drug allergy, J. Allergy Clin. Immunol., 74: 567–72.
12. Du W., Lehr V.T., Lieh-Lai M., Koo W., Ward R.M., Rieder M.J., Van Den Anker J.N., Reeves J.H., Mathew M., Lulic- Botica M. and Aranda, J.V. (2013) An Algorithm to Detect Adverse Drug Reactions in the Neonatal Intensive Care Unit, J. Clin. Pharma., 53: 87–95.
13. Du W., Tutag Lehr, V., Caverly M., Kelm L., Reeves J. and Lieh-Lai M. (2013) Incidence and Costs of Adverse Drug Reactions in a Tertiary Care Pediatric Intensive Care Unit, J. Clin. Pharma., 53: 567–573.
14. Hamilton H.J., Gallagher P.F. and O'Mahony D. (2009) Inappropriate prescribing and adverse drug events in older people, BMC Geriatrics, 9: 5-8.
PMid:19175914 PMCid:PMC2642820
15. Miller W.H., Griffin C.E. and Campbell, K.L. (2013) Bacterial Skin Diseases. In: Miller W.H., Griffin C.E. and Campbell K.L. editor. Muller and Kirk's Small Animal Dermatology. 7th edition. Elsevier, St. Louis, Missouri, USA. p191–192.
16. Harle D.G., Baldo, B.A. and Wells J.V. (1988) Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole, Mol. Immunol., 25: 1347–1354.
17. Brackett C.C., Singh H. and Block J.H. (2004) Likelihood and Mechanisms of Cross-Allergenicity Between Sulfonamide Antibiotics and Other Drugs Containing a Sulfonamide Functional Group, Pharmacotherapy, 24: 856–870.
18. Voie K.L., Lucas B.E., Schaeffer D., Kim D., Campbell K.L. and Lavergne S.N. (2013) The effect of 'allergenic' and 'nonallergenic' antibiotics on dog keratinocyte viability in vitro, Vet. Dermatol., 24: 501–e119.
19. Romano A., Gaeta F., Valluzzi R.L., Caruso C., Rumi G. and Bousquet P.J. (2010) IgE-mediated hypersensitivity to cephalosporins: Cross-reactivity and tolerability of penicillins, monobactams, and carbapenems, J. Allergy Clin. Immunol., 126(5): 994-999.
20. James C.W. and Gurk-Turner C. (2001) Cross-reactivity of beta-lactam antibiotics, BUMC Proceed, 14: 106–107.
21. Fox S. and Park M.A. (2011) Penicillin skin testing in the evaluation and management of penicillin allergy, Annals of Allergy, Asthma & Immunol., 106 (1): 1-7.
22. Crowson A.N. and Magro C.M. (1999) Recent advances in the pathology of cutaneous drug eruptions, Dermatol. Clin, 17: 537–560.
23. Brown S.A. and Garry, F.B. (1988) Comparison of serum and renal gentamicin concentrations with fractional urinary excretion tests as indicators of nephrotoxicity, J. Vet. Pharmacol. Ther, 11(4): 330-7.
24. Frazier D.L., Aucoin D.P. and Riviere J.E. (1988) Gentamicin pharmacokinetics and nephrotoxicity in naturally acquired and experimentally induced disease in dogs, J. Am. Vet. Med. Assoc, 192(1): 57-63.
25. Sandhu H.S. and Rampal S. (2006) Essentials of Veterinary Pharmacology and Therapeutics. 1st Edition. Kalyani, New Delhi. p1093-1186.
26. Hsu W.H. and Ahrens F.A. (2013) Drug Interactions and Adverse Drug Reactions. Handbook of Veterinary Pharmacology. Wiley Publishers. p461-470.
27. McDuffie J.E., Gao J., Ma J., La D., Bittner A., Sonee M., Wagoner M. and Snook S. (2013) Novel genomic biomarkers for acute gentamicin nephrotoxicity in dog, Open J. Mol. Integr. Physiol., 3: 125-133.
28. Xie J., Talaska A.E. and Schacht J. (2011) New developments in aminoglycoside therapy and ototoxicity, Hearing Res., 281: 28-37.
PMid:21640178 PMCid:PMC3169717
29. Fischel-Ghodsian N. (1999) Genetic factors in aminoglycoside toxicity, Ann. N. Y. Acad. Sci, 884: 99–109.
30. Sykes J.E. and Papich M.G. (2014) Antibacterial Drugs, Canine and Feline Infectious Diseases, Saunders, W.B., p66- 86.
31. Stahlmann R. and Hartmut L. (2010) Safety Considerations of Fluoroquinolones in the Elderly, Drugs Aging, 27(3): 193-209.
32. Simonin M.A., Gegout-Pottie P., Minn A., Gillet P., Netter P. and Terlain, B. (1999) Proteoglycan and collagen biochemical variations during fluoroquinolone- induced chondrotoxicity in mice, Antimicrob. Agents Chemother, 43: 2915-2921.
PMid:10582882 PMCid:PMC89587
33. Hall M.M., Finnoff J.T. and Smith J. (2011) Musculoskeletal Complications of Fluoroquinolones: Guidelines and Precautions for Usage in the Athletic Population, Phys. Med. Rehabil., 3(2): 132-142.
34. Stahlmann R., Kuhner S., Shakibaei M., Flores J., Vormann J. and van Sickle D.C. (2000) Effects of magnesium deficiency on joint cartilage in immature beagle dogs: immunohistochemistry, electron microscopy, and mineral concentrations, Arch. Toxicol., 73: 573-580.
35. Hinkle D.M., Dacey M.S., Mandelcorn E., Kalyani P., Mauro J., Bates J.H., Soukasian S.H., Holland G.N., Foster C.S., Fraunfelder F.T., Davis J.L. and Fraunfelder F.W. (2012) Bilateral uveitis associated with fluoroquinolone therapy, Cutaneous Ocul Toxicol., 31(2): 111-116.
36. Sathasivam S. and Lecky B. (2008) Statin induced myopathy, Brit. Med. J., 337: 2286.
37. Noli C. and Boothe D. (1999) Macrolides and lincosamides, Vet. Dermatol., 10: 217–223.
38. Rice D.A. and McMurray C.H. (1983) Ketosis in dairy cows caused by low levels of lincomycin in concentrated feed, Vet. Rec., 113: 495-6.
39. Richard A.H. (2001) Veterinary Pharmacology and Therapeutics. 8th edition. Iowa State University: Blackwell, Iowa, U.S.A., p844.
40. Giguθre S., Prescott J.F. and Dowling P.M. (2013) Antimicrobial Therapy in Veterinary Medicine. 5th edition. John Wiley & Sons, Iowa State University.,p67.
41. Prayle A., Watson A.A., Fortnum H. and Smyth A. (2010) Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis, Thorax, 65(7): 654-658.
PMid:20627927 PMCid:PMC2921289
42. Trumic E., Pranjic N., Begic L., Becic F. and Asceric M. (2012) Idiosyncratic Adverse Reactions of Most Frequent Drug Combinations Longterm Use Among Hospitalized patients with Polypharmacy, Med. Arch., 66 (4): 243-248.